DCP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.985800E-01
Normal-vs-Stage2
4.249400E-01
Normal-vs-Stage3
3.044200E-01
Normal-vs-Stage4
4.328000E-01
Stage1-vs-Stage2
7.108800E-01
Stage1-vs-Stage3
2.215200E-01
Stage1-vs-Stage4
6.952600E-01
Stage2-vs-Stage3
1.400380E-01
Stage2-vs-Stage4
9.718000E-01
Stage3-vs-Stage4
1.432390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.205200E-01
Normal-vs-AfricanAmerican
3.757800E-01
Normal-vs-Asian
3.386200E-01
Caucasian-vs-AfricanAmerican
5.021400E-01
Caucasian-vs-Asian
1.224570E-01
AfricanAmerican-vs-Asian
6.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.101400E-01
Normal-vs-Female
4.191400E-01
Male-vs-Female
7.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.218000E-01
Normal-vs-Age(41-60Yrs)
4.838800E-01
Normal-vs-Age(61-80Yrs)
3.840600E-01
Normal-vs-Age(81-100Yrs)
3.947200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.954600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.667600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.895800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.964400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.447900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.921000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.952000E-01
Normal-vs-Daily Drinker
3.919800E-01
Normal-vs-Weekly Drinker
3.569000E-01
Normal-vs-Occasional Drinker
4.308200E-01
Normal-vs-Social Drinker
4.202800E-01
Non Drinker-vs-Daily Drinker
9.539200E-01
Non Drinker-vs-Weekly Drinker
5.123400E-01
Non Drinker-vs-Occasional Drinker
5.229800E-01
Non Drinker-vs-Social Drinker
6.103000E-01
Daily Drinker-vs-Weekly Drinker
5.211600E-01
Daily Drinker-vs-Occasional Drinker
4.465600E-01
Daily Drinker-vs-Social Drinker
5.816800E-01
Weekly Drinker-vs-Occasional Drinker
2.018000E-01
Weekly Drinker-vs-Social Drinker
2.744000E-01
Occasional Drinker-vs-Social Drinker
8.318000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.660400E-01
Normal-vs-Grade 2
7.968800E-01
Normal-vs-Grade 3
8.071600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.269400E-01
Grade 1-vs-Grade 3
2.910600E-01
Grade 1-vs-Grade 4
7.660400E-01
Grade 2-vs-Grade 3
8.111400E-01
Grade 2-vs-Grade 4
7.968800E-01
Grade 3-vs-Grade 4
8.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.199200E-01
Normal-vs-NonDiabetic
3.929400E-01
Diabetic-vs-NonDiabetic
4.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.908400E-01
Normal-vs-NoPancreatitis
4.017400E-01
Pancreatitis-vs-NoPancreatitis
8.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.042200E-01
Normal-vs-N1
4.239200E-01
N0-vs-N1
5.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.325200E-01
Normal-vs-TP53-NonMutant
3.544800E-01
TP53-Mutant-vs-TP53-NonMutant
5.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
